Migraine and cardiocerebrovascular risk in women

Authors: Agostoni, Elio; Aliprandi, Angelo

Source: Women's Health, Volume 3, Number 3, May 2007 , pp. 369-379(11)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

The interest of the medical community has recently focused on the relationship between gender and cardiocerebrovascular risk. In this paper, we will first review gender differences in cardiocerebrovascular disorders, then we will discuss the existing evidence on the links between migraine and stroke and cardiovascular disease in women, and speculate on the possible physiopathological interpretations of this emerging epidemiological link. In the third part of this work, we will address the issue of the effect of sex hormones on vascular risk, and consider the evidence concerning the safety of oral contraceptives and hormone-replacement therapy. Finally, we will outline the main trends of future research and its possible clinical and therapeutic implications

Keywords: cardiovascular diseases; cerebrovascular diseases; gender; hormone-replacement therapy; migraine; oral contraceptives; patent foramen ovale; vascular risk

Document Type: Research article

DOI: http://dx.doi.org/10.2217/17455057.3.3.369

Affiliations: 1: 1Department of Neurosciencies, Neurology Division, Manzoni Hospital, Lecco, Italy., Email: elio.agostoni@ospedale.lecco.it

Publication date: 2007-05-01

More about this publication?

Women's Healthprovides a forum for specialists addressing those conditions that are unique to women or far more prevalent in women than in men. The journal focuses on current and emerging topics relating to the safe and effective management of therapy in women, taking into account issues such as key areas such as women's physiology and life-cycle hormonal changes, with all articles subject to rigorous peer review.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
E-Access Trials
ingentaconnect is not responsible for the content or availability of external websites